SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

IMA

ImageneBio, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 10h ago SEC0001140361-26-043771
Passive stake amendment
Actionable Insight • Neutral

This is a purely administrative correction with no change in stake or intent. Monitor for any future conversion to a 13D if Blue Owl's investment approach shifts, but no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Blue Owl Capital Holdings LP filed an amended Schedule 13G disclosing beneficial ownership of 1,135,081 shares of ImageneBio (9.11% of shares outstanding as of October 31, 2026). The filing corrects an inadvertent omission of 217,389 shares acquired in a private placement at the IPO that were not reported in prior filings; the stake level is unchanged from the previously reported position. This is a routine administrative amendment with no change in investment intent or position size.

Key Financial Metrics

Stake
9.11%
Investor
Blue Owl Capital Holdings LP
Investor Type
hedge fund

Key Facts

  • Blue Owl Capital Holdings LP reports 1,135,081 shares (9.11%) of ImageneBio as of September 30, 2026
  • Percentage based on 12,456,281 shares outstanding as of October 31, 2026 per the issuer's 10-Q
  • Amendment corrects omission of 217,389 shares acquired in a private placement at the IPO, inadvertently left out of the initial 13G and first amendment
  • No change in actual position size or investment intent; passive filer under Rule 13d-1(b)

Financial Impact

No material financial impact; administrative correction only

Risk Factors

  • None from this filing; the correction resolves a prior reporting omission

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001140361-26-043771
Document: 0001140361-26-043771-index.html0001140361-26-043771
Document: 0001140361-26-043771.txt0001140361-26-043771

Track record

10 reports on IMA

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +27.94% at T+60 after the Aug 7, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $3.50 Now $3.20 −8.57% settles Feb 12
  2. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $3.81 Now $3.20 −16.01% settles Feb 8
  3. Aug 7, 202614w ago EFFECT Bearish 5/10 Entry $5.69 to $4.10 Now $3.20 +43.76% ▲ +27.94% +25.81% vs SPY
  4. Jun 26, 202620w ago 8-K Neutral 3/10 Entry $6.07 to $4.85 Now $3.20 −47.28% ▼ −20.10% −24.48% vs SPY
  5. Apr 30, 202628w ago DEFA14A Neutral 3/10 Entry $5.66 to $5.76 Now $3.20 −43.46% ▲ +1.77% −1.30% vs SPY
  6. Apr 13, 202631w ago 8-K Bearish 6/10 Entry $6.05 to $5.93 Now $3.20 +47.11% ▲ +2.07% +10.99% vs SPY
  7. Apr 13, 202631w ago Press Release Bearish 6/10 Entry $6.05 to $5.93 Now $3.20 +47.11% ▲ +2.07% +10.99% vs SPY
  8. Apr 6, 202632w ago EFFECT Neutral 3/10 Entry $4.55 to $5.77 Now $3.20 −29.67% ▲ +26.81% +13.34% vs SPY
  9. Mar 17, 202634w ago Press Release Neutral 3/10 Entry $5.83 to $5.71 Now $3.20 −45.06% ▼ −1.97% −13.50% vs SPY
  10. Mar 10, 202635w ago Press Release Neutral 4/10 Entry $6.07 to $5.45 Now $3.20 −47.28% ▼ −10.21% −21.90% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 6h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026